ProPhase Labs, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-14.7M | $-53.4M | $-16.8M | $18.5M | $6.3M | $-2.1M | $-3.1M | $-1.7M |
| Depreciation & Amortization | $4.8M | $6.2M | $6.1M | $4.7M | $3.2M | $449.0K | $398.0K | $383.0K |
| Depreciation | $2.2M | $4.2M | $3.1M | $2.3M | $1.9M | $375.0K | $82.0K | $383.0K |
| Amortization | $2.6M | $2.6M | $2.9M | $2.4M | $1.4M | $73.0K | — | — |
| Stock-Based Compensation | $1.9M | $3.6M | $3.5M | $4.0M | $3.2M | $1.5M | $744.0K | $634.0K |
| Net Cash from Operating Activities | $-8.3M | $-17.5M | $-11.9M | $28.6M | $-13.6M | $-2.6M | $-841.0K | $-2.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $906.0K | $2.1M | $3.9M | $4.2M | $1.7M | $228.0K | $140.0K |
| Business Acquisitions | — | $0 | $2.9M | $0 | $9.1M | $2.5M | — | — |
| Net Cash from Investing Activities | $920.0K | $2.4M | $-1.4M | $-2.1M | $-19.7M | $-1.0M | $5.5M | $11.9M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | $0 | $9.4M | $4.5M | — | $5.8M | $11.7M |
| Stock Repurchases | — | $0 | $588.0K | $2.2M | $917.0K | — | — | — |
| Net Cash from Financing Activities | $6.8M | $14.2M | $5.8M | $-26.0M | $35.1M | $10.0M | $-5.8M | $-11.4M |
| Net Change in Cash | $-588.0K | $-931.0K | $-7.5M | $451.0K | $1.8M | $6.4M | $-1.1M | $-1.6M |
| Free Cash Flow | $-8.3M | $-18.4M | $-14.0M | $24.6M | $-17.9M | $-4.3M | $-1.1M | $-2.3M |